NCT01855633

Brief Summary

Stroke is one of the major causes of death in the World. Many stroke survivors may suffer from long-term sequelae of stroke such as hemiplegia. The effects of rehabilitation therapy are limited. The development of new treatment strategies is essential. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive method to stimulate the focal area of the brain for restoring brain function. The aim of this study is to investigate the therapeutic effect of rTMS on the motor recovery in patients with hemiplegic stroke.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
177mo left

Started Apr 2013

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Apr 2013Dec 2040

Study Start

First participant enrolled

April 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 10, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2013

Completed
26.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2039

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2040

Last Updated

February 4, 2025

Status Verified

February 1, 2025

Enrollment Period

26.7 years

First QC Date

May 10, 2013

Last Update Submit

February 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Keyboard tapping test

    Participants will be asked to tap a key of a computer keyboard as fast as possible in five seconds. They will be asked to do three times. We will measure the number of tapping. The primary outcome will be the averaged data of the numbers.This will be done before and after 5-day rTMS intervention.

    1 day

Study Arms (3)

Tradtional Theta burst stimulation (TBS) rTMS

EXPERIMENTAL

Participants will receive continuous theta burst stimulation (cTBS) rTMS to contralesional hemisphere based on a previous study (Huang et al., 2005)

Device: Traditional Theta burst stimulation (TBS)

Modified TBS rTMS

ACTIVE COMPARATOR

Participants will receive modified cTBS rTMS to contralesional hemisphere based on a previous study (Nyffeler et al., 2006)

Device: Modified TBS rTMS

Sham rTMS

SHAM COMPARATOR

Participants will receive sham cTBS rTMS to contralesional hemisphere.

Device: Sham rTMS

Interventions

Tradtional Theta burst stimulation (TBS) rTMS
Modified TBS rTMS
Sham rTMSDEVICE
Sham rTMS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stroke patients with motor weakness
  • Medical research council (MRC) grade 0-4
  • More than 2 weeks after stroke onset
  • Age 18 years and older
  • Able to provide consent for the protocol

You may not qualify if:

  • History of previous symptomatic stroke
  • pregnant women
  • Persons with surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), intracardiac lines that may pose a physical hazard during magnetic stimulation will also be excluded
  • Patients with history of seizure disorder or epilepsy
  • Subjects without the capacity to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dongtan Sacred Heart Hospital

Hwaseong-si, Gyeonggi-do, 445-170, South Korea

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Suk Yun Kang, MD, PhD

CONTACT

Ah-Young Jun, MD, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

May 10, 2013

First Posted

May 16, 2013

Study Start

April 1, 2013

Primary Completion (Estimated)

December 1, 2039

Study Completion (Estimated)

December 1, 2040

Last Updated

February 4, 2025

Record last verified: 2025-02

Locations